Axiological and diachronic dimensions - Yannick Fouquet

Health problem and current use of the technology. • 2. Description and technical charac. of the technology. • 3. Safety. • 4. Effectiveness (mortality, morbidity ...
595KB taille 31 téléchargements 343 vues
ISG2010 International Society for Gerontechnology 7th World Conference Vancouver, Canada, 27-29 May 2010 

Outline of a general framework for assessing e-health and gerontechnology applications: Axiological and diachronic dimensions V. Rialle*, N. Vuillerme*, A. Franco**, Y. Fouquet* *University and Universitary Hospital of Grenoble, France **University and Universitary Hospital of Nice, France French Society for Gerontechnology National Reference Center for Home care and Autonomy

1

Summary

  Introduction   “Does

it work ? Is it useful ? Are users satisfied ?”

  Analysis  

Quick review of disciplines, languages, values …

  Proposition  

TEMSED : an evaluation framework for structuring complexity

  Discussion 2

Introduction   Fundamental reccurrent questions « Does it work? Is it usefulv? Are users satisfied? "   How does it cost ?   How and what does it spare ?   Does it hurt ?   Impacts on pratice ?   Impacts on elders empowerment ?   Etc.  

3

Introduction   Areas of investigation  

(Geron)Technology and service for ageing, social connectedness, health, autonomy… •  Great number of papers, experiment reports, issues…

 

Evaluation •  Social effectiveness, medical effectiveness, cost effectiveness, quantitative/qualitative assessment, ethnographical evaluation… •  Profusion of methods •  Profusion of brakes, biases, obstacles –  Lot of ‘partial’ evaluations •  Absolute need ! –  From decision makers, health policy makers

  Necessity to conduct reliable multi-dimensional evaluations   to share a common language which transcends diversity  

4

Evaluation reports refer to:   Scientific disciplines  

With specific methodological approaches

  Common language and assessment tools ICF   Plethora of evaluation scales ans standardised questionnaires  

  Values  

What is worth to be considered

  Magnitudes  

Size of the study, invested efforts, durations

5

Scientific disciplines of gerontechnology

Geron - technology

(from JEMH van Bronswijk, Eindhoven University of Technology, 2008)

6

Common language: International Classification of Functioning, Disability and Health (ICF)

  ICF:  

« (…) the international standard to describe and measure health and disability » •  www.who.int/classifications/icf/en/

  A common language  

For referring to •  •  •  • 

 

Body functions Body structures Activities and participation Environmental factors

Within sudies of •  Outcomes, quality of life or environmental factors

7

Values - Example 1   Danish Centre for Health Technology Assessment   5

domains of « values »

•  Technology •  Patient •  0rganization •  Economy •  Ethics –  Health Technology Assessment World Europe 2009 http://www.healthnetworkcommunications.com/2009/ hta/ 8

Values - Example 2   European network for Health Technology Assessment (EUnetHTA)   Nine domains of values •  1. Health problem and current use of the technology •  2. Description and technical charac. of the technology •  3. Safety •  4. Effectiveness (mortality, morbidity, function, QoL, patient satisfaction) •  5. Costs, economic evaluation •  6. Ethical aspects •  7. Organisational aspects •  8. Social aspects •  9. Legal aspects –  MethoTelemed: Users’ needs: Report on the results of Workshop One (oct 2009)

9

Magnitude Example of the Clinical trails’ phases   Pre-clinical studies  

n vitro (test tube) and in vivo (animal or cell culture)

  Phase 0  

exploratory

  Phase I  

first stage of testing in human subjects; small groups

  Phase II  

to assess how well the drug works; on larger groups (20-300)

  Phase III  

randomized controlled multicenter trials; large groups

  Phase IV  

Post marketing surveillance trials

10

Proposition

11

Proposition for structuring complexity: The TEMSED approach   Axiology Technology Ergonomics Medicine Society Economics Deontology

  Magnitude Design: Research and development Phase I: technical aspects (reliability, robustness…) Phase II: relation between the user and the device Phase III: probing results in various terms Phase IV: economical viability and dissemination capacities

12

Two main dimensions   Axiology –  from Greek ἀξίᾱ, axiā, "value, worth"; and -λογία, -logia). Axiology is the study of quality or value (http://en.wikipedia.org/wiki/Axiology)

Question tackled : What are the « values », in the broad sense, of the evaluation ?   Includes scientific disciplines, economy, deontology…  

  Magnitude –  from Latin magnus, "grand »; with the suffix itude

Question tackled : What is the extent (size, duration, efforts…) of the evaluation ?   Includes all procedural aspects  

13

TEMSED

Deontology Axiology

Economics Society Medicine Ergonomics Technology

Design

Phase I

Phase II

Phase III

Phase IV

Magnitude 14

Discussion - conclusion   TEMSED not a definite model stricto sensus   Is not intended to provide all solutions regarding assessment methods   Provides a framework   Is

•  For gathering complimentary assessment traditions •  For helping to systematise evaluation   Is

intended to be used, namely

•  By the French National Reference Center for home care and autonomy (CNR SDA) •  By the French Chapter of ISG   May

be the summary of a vast handbook of evaluation

•  to write together… 15

16

 

Health Technology Assessment World Europe 2009 •  http://www.healthnetworkcommunications.com/2009/hta/

NICE   AETMIS  

•  www.aetmis.gouv.qc.ca  

Interdisciplinarity of Gerontechnology •  JEMH van Bronswijk, Eindhoven University of Technology •  http://www.slidefinder.net/I/ Interdisciplinarity_Gerontechnology_2008_International_Master/ 10081151

 

MethoTelemed: Methodology to assess telemedicine applications (SMART 2008/0064 – O.J.2008/S 107-142555) •  http://ec.europa.eu/information_society/newsroom/cf/ itemlongdetail.cfm?item_id=5038

17

 

MethoTelemed: Users’ needs: Report on the results of Workshop One (oct 2009) •  http://telemed.custompublish.com/getfile.php/ 1023659.357.bbbrftaxqx/MethoTelemed-Users_needsReport_on_the_results_of_Workshop_One.pdf

 

« Revue systématique des effets de la télésurveillance à domicile dans le contexte du diabète, des maladies pulmonaires et des maladies cardiovasculaires » •  ETMIS 2009; VOL. 5 : NO 3 (Agence d’Evaluation de Technologies et des Modes d’Intervention en Santé).

 

Clinical trials (Wikipedia)

18